|1.||Yoshida, Hiromi: 3 articles (08/2013 - 01/2007)|
|2.||Mizushina, Yoshiyuki: 3 articles (08/2013 - 01/2007)|
|3.||Sugawara, Fumio: 2 articles (08/2013 - 01/2009)|
|4.||Takeuchi, Toshifumi: 2 articles (08/2013 - 01/2009)|
|5.||Huismans, Henk: 1 article (12/2015)|
|6.||Theron, Jacques: 1 article (12/2015)|
|7.||Pretorius, Jakobus M: 1 article (12/2015)|
|8.||Khanlari, Zahra: 1 article (01/2014)|
|9.||Majidi-Gharenaz, Nasrin: 1 article (01/2014)|
|10.||Ghaderi, Mostafa: 1 article (01/2014)|
01/01/1998 - "Due to the limitations of transient expression systems, the vaccinia/T7 RNA polymerase hybrid system is suited for expression analysis on a small scale, and for studying intracellular interactions of the enzyme as demonstrated by immunofluorescence microscopy studies. "
06/01/1990 - "The vaccinia recombinant, vTF7-3, which expresses the bacteriophage T7 RNA polymerase was used in transient expression studies using plasmids containing a T7 promoter upstream of the FMDV cassettes. "
08/01/2010 - "The currently available reverse genetics system for Novirhabdovirus is based on vaccinia-driven T7 RNA polymerase expression. "
12/01/2007 - "In one of the most efficient strategies developed so far, the gene to be expressed is positioned downstream of a bacteriophage T7 promoter within the vaccinia genome and transcribed by the T7 RNA polymerase, also encoded by the vaccinia virus genome. "
07/01/2003 - "Our goal was to engineer a system where replication of the vaccinia virus-T7 vector could be blocked, yet allow for sufficient T7 RNA polymerase expression to enable genetic rescue. "
|2.||Contagious Ecthyma (Orf)
01/01/2008 - "To resolve the apparent discrepancies associated with the mechanism of core+1 translation, we examined the expression of the HCV-1 and HCV-1a (H) core+1 ORF in a cytoplasmic transcription system based on Huh-7/T7 cells that constitutively synthesize the T7 RNA polymerase in comparison to that in Huh-7 cells. "
02/01/1997 - "No enzyme activity could be ascribed to the second ORF (orfW), despite the production of a visible protein using a T7 RNA polymerase system. "
05/01/1996 - "To study the role of the A17L protein in morphogenesis, we constructed recombinant vaccinia viruses in which the endogenous A17L ORF was deleted and a copy of the ORF under the control of the bacteriophage T7 RNA polymerase and the Escherichia coli lac repressor was inserted into an alternative site in the vaccinia virus genome. "
09/15/1999 - "The IS 200 transposase, a 16 kDa polypeptide encoded by the single open reading frame (ORF) of the insertion element, has been identified using an expression system based on T7 RNA polymerase. "
10/01/1993 - "Expression of the middle operon under the control of a T7 promoter and T7 RNA polymerase resulted in production of two polypeptides of 15 (ORF 120) and 16.5 kDa (C). "
10/01/2013 - "pylori infection A fragment of the cagA gene was cloned into a prokaryotic T7 RNA polymerase expression vector. "
01/05/2008 - "One is mediated by the T7 RNA polymerase supplied either by a constitutively expressing cell line or by transfection of expression plasmids and is thus independent from infection with a helper virus. "
02/01/2005 - "Additionally, the virus rescue system was optimized by changing the infection dose of the recombinant vaccinia virus expressing T7 RNA polymerase. "
08/01/2004 - "In a normal infection about 850 bp of the bacteriophage T7 genome is ejected into the cell, the remainder of the genome is internalized through transcription by Escherichia coli and then T7 RNA polymerase. "
07/16/2004 - "T7 RNA polymerase selectively transcribes T7 genes during infection but is also involved in DNA replication, maturation and packaging. "
|4.||Hepatocellular Carcinoma (Hepatoma)
10/01/2008 - "Baculovirus mediated production of infectious hepatitis C virus in human hepatoma cells stably expressing T7 RNA polymerase."
08/24/2007 - "Furthermore, when hepatoma specific AFP promoter was introduced to control T7 RNA polymerase expression, the RNA interference was permitted only in AFP-producing cells. "
08/01/2004 - "In this present study, an alternative approach was used to in vitro synthesize enhanced green fluorescent protein (EGFP) specific short interfering RNA (siRNA) using T7 RNA polymerase, and a pEGFP-N1 transfected, human hepatoma cell line Huh-7 derived Huh-7-N cell clone was established. "
|5.||Tuberous Sclerosis (Bourneville's Disease)
|1.||Complementary DNA (cDNA)
|2.||DNA (Deoxyribonucleic Acid)
|3.||RNA (Ribonucleic Acid)
|5.||Small Interfering RNA (siRNA)
|7.||Caspase 3 (Caspase-3)
|9.||enhanced green fluorescent protein
|10.||triphosphoric acid (triphosphate)